Shareholder alert: pomerantz law firm investigates claims on behalf of investors of sab biotherapeutics, inc. - sabs

New york, nov. 25, 2021 /prnewswire/ -- pomerantz llp is investigating claims on behalf of investors of sab biotherapeutics, inc. ("sab" or the "company") (nasdaq: sabs). such investors are advised to contact robert s.

SABS Ratings Summary

SABS Quant Ranking